Last $59.38 USD
Change Today -0.62 / -1.03%
Volume 613.3K
MD On Other Exchanges
Symbol
Exchange
New York
Mexico
As of 8:04 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

mednax inc (MD) Snapshot

Open
$60.00
Previous Close
$60.00
Day High
$60.11
Day Low
$59.32
52 Week High
04/1/14 - $64.51
52 Week Low
05/2/13 - $42.98
Market Cap
5.9B
Average Volume 10 Days
495.0K
EPS TTM
$2.78
Shares Outstanding
100.2M
EX-Date
--
P/E TM
21.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDNAX INC (MD)

Related News

No related news articles were found.

mednax inc (MD) Related Businessweek News

No Related Businessweek News Found

mednax inc (MD) Details

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, and other pediatric subspecialties care physician services in the United States and Puerto Rico. It offers neonatal care services, including clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia care services through physician anesthesiologists, nurse anesthetists, anesthesia assistants, and other clinicians; anesthesia subspecialty care; and acute and chronic pain management services through outpatient medical offices, hospital clinics, and ambulatory service centers. The company also provides maternal-fetal care services comprising inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, obstetricians, and other clinicians, such as maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. Its pediatric cardiology care services consist of inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other clinicians; and other pediatric subspecialty care services include care of critically ill or injured children and adolescents; and clinical services in other areas of hospitals, primarily in the pediatric emergency room, labor and delivery area, and newborn nursery and pediatric department. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

6,500 Employees
Last Reported Date: 02/12/14
Founded in 1979

mednax inc (MD) Top Compensated Officers

Co-Founder, Chief Executive Officer, Director...
Total Annual Compensation: $1.0M
President and Chief Operating Officer
Total Annual Compensation: $600.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $400.0K
President of American Anesthesiology
Total Annual Compensation: $500.0K
President of Pediatrix Medical Group
Total Annual Compensation: $450.0K
Compensation as of Fiscal Year 2013.

mednax inc (MD) Key Developments

W. Scott Brosche to Work as Medical Director of Anesthesiology Practice

MEDNAX, Inc. announced the acquisition of Fredericksburg Anesthesia Associates, Inc. The practice will become part of MEDNAX's American Anesthesiology division and is the third Virginia-based anesthesia practice to join the division. W. Scott Brosche, M.D. will serve as medical director for the practice. This was a cash transaction, and it is expected to be immediately accretive to earnings.

MEDNAX, Inc. Names Charles Lynch as Vice President, Strategy and Investor Relations

MEDNAX, Inc. announced that it has named Charles Lynch as Vice President, Strategy and Investor Relations. In his role, Lynch will collaborate with MEDNAX's senior management team to develop and continue the Company's growth and competitive strategy. He will also have primary responsibility for managing MEDNAX's communications with its public shareholders and the general investment community. Lynch joins MEDNAX with 20 years of experience in the healthcare investment field. Prior to joining the Company, he was a Managing Director in the healthcare-services practice at Westwicke Partners, a strategic investor-relations advisory firm. Prior to Westwicke, Lynch was an investment banker with Oppenheimer & Co. and a senior research analyst at CIBC World Markets, Schroder & Co., and Bankers Trust.

MEDNAX, Inc. Presents at Raymond James 35th Annual Institutional Investors Conference, Mar-03-2014 09:15 AM

MEDNAX, Inc. Presents at Raymond James 35th Annual Institutional Investors Conference, Mar-03-2014 09:15 AM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, Florida, United States. Speakers: Vivian Lopez-Blanco, Chief Financial Officer, Principal Accounting Officer and Treasurer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MD:US $59.38 USD -0.62

MD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $20.73 USD +0.25
Mettler-Toledo International Inc $234.10 USD -0.20
PerkinElmer Inc $44.31 USD -0.23
ResMed Inc $47.41 USD +0.66
Cooper Cos Inc/The $130.53 USD +1.23
View Industry Companies
 

Industry Analysis

MD

Industry Average

Valuation MD Industry Range
Price/Earnings 21.6x
Price/Sales 2.8x
Price/Book 2.6x
Price/Cash Flow 18.8x
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDNAX INC, please visit www.mednax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.